27Mar

HORIBA Medical launches D-Dimer reagent for Yumizen G Haemostasis range

Horibalogo

Northampton, UK – 21 March 2019 – HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G haemostasis range of instruments. The new Yumizen G DDi 2 (D-Dimer) reagent kit offers a key measurement and reference exclusion test for the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It can also be used for monitoring the progress and effectiveness of treatment of Disseminated Intravascular Coagulation (DIC).

HORIBA Medical’s new D-Dimer reagent kit is available for its full range of coagulation instruments which covers the needs of any laboratory. The dedicated haemostasis portfolio includes the fully automatic Yumizen G800, Yumizen G1500 and Yumizen G1550, as well as semi-automatic Yumizen G200 and Yumizen G400 analysers. Using antibody-coated latex particles and measured via the immuno-turbidimetric channels of these Yumizen G instruments, the new reagent kit delivers D-Dimer results consistency across the range.

The D-Dimer assay when used on very compact coagulation screening platforms such as the Yumizen G400DDi and Yumizen G200, which also have combined immuno-turbidimetric and chromogenic assay capabilities, is particularly ideal for small laboratories, hot labs and as backup. On these semi-automatic systems, the Yumizen G DDi 2 reagent kit offers an innovative combination of immuno-turbidimetric test capability and pre-calibrated ready-to-use reagent.

Offering a cost-efficient solution, the new assay minimises preparation time due to its ready-to-use liquid format. Furthermore, as the reagent is pre-calibrated it removes the need for a costly and time-consuming calibration step. Its high stability and optimised volume packaging also avoids wastage.

HORIBA Medical’s new D-Dimer test kit is fully compliant with Gold Standard performances, having a Negative Predictive Value of 99% and an absence of hook effect up to 25 µg FEU/ml. It also offers slope check and post dilution function on both fully automatic and semi-automatic systems with a cut-off value at 0.5 µg FEU/ml.

For more information on HORIBA UK Ltd. Medical and its products, including its new Yumizen GDDi 2 (D-Dimer) kit and Yumizen G haemostasis range of analysers, please visit: www.horiba.com/uk/medical.

Related

Protect Your Samples from Acidification When Shipped On Dry Ice

The new ProtectR® tubes, now available from Alpha Laboratories, have the only container closure syst...

Read More >

Isohelix Double Registers its DNA Saliva and Buccal Cell Collectors with the Chinese CFDA.

Isohelix announces that their range of GenefiX DNA Saliva and Isohelix DNA Buccal Cell Collectors ar...

Read More >

£1M funding for the development of a quantitative lateral flow Smartphone Reader

Abingdon Health announces £1M Innovate UK funding for the development of a fully quantitative latera...

Read More >

OGT launches breakthrough CytoSure NGS panel for constitutional cytogenetics

Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one a...

Read More >

Study confirms HORIBA POCT analyser enables earlier clinical decision-making in emergency paediatrics

Northampton, UK – 20th March 2018 – HORIBA UK Ltd, Medical announces that in a study recently unde...

Read More >

Proteome Sciences plc announce Good Clinical Laboratory Practice Accreditation

Proteome Sciences are pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) ac...

Read More >